Rauschert, I.; Aldunate, F.; Preussner, J.; Arocena-Sutz, M.; Peraza, V.; Looso, M.; Benech, J. C.; Agrelo, R.: Promoter hypermethylation as a mechanism for Lamin A/C silencing in a subset of neuroblastoma cells. PLOS ONE 12 (4), e0175953 (2017)
Josipovic, I.; Fork, C.; Preussner, J.; Prior, K.-K.; Iloska, D.; Vasconez, A. E.; Labocha, S.; Angioni, C.; Thomas, D.; Os, N. F.et al.; Looso, M.; Pullamsetti, S. S.; Geisslinger, G.; Steinhilber, D.; Brandes, R. P.; Leisegang, M. S.: PAFAH1B1 and the lncRNA NONHSAT073641 maintain an angiogenic phenotype in human endothelial cells. ACTA PHYSIOLOGICA 218 (1), pp. 13 - 27 (2016)
Josipovic, I.; Leisegang, M. S.; Fork, C.; Preussner, J.; Looso, M.; Brandes, R. P.: PAFAH1B1 is important for endothelial cell angiogenic function. ACTA PHYSIOLOGICA 216 (2016)
Leisegang, M. S.; Fork, C.; Preussner, J.; Looso, M.; Brandes, R. P.: The LncRNA HIF1 alpha-AS1 mediates the response to acriflavine in human endothelial cells. ACTA PHYSIOLOGICA 216 (2016)
Researchers at the Max Planck Institute develop a new pharmacological approach that specifically targets receptor interactions – with implications for immune defense and blood pressure regulation
A team of researchers at the Max Planck Institute for Heart and Lung Research, led by Prof. Dr. Didier Y.R. Stainier, has been awarded a prestigious ERC Proof of Concept (PoC) grant to advance a groundbreaking RNA-based therapeutic strategy for Duchenne Muscular Dystrophy (DMD).